Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $46.0000 (5.99%) ($44.4000 - $47.2000) on Sat. Aug. 1, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.54% (three month average) | RSI | 39 | Latest Price | $46.0000(5.99%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.5% a day on average for past five trading days. | Weekly Trend | CAPR declines -5.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting CAPR price | CAPR will decline at least -1.77% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.77% (StdDev 3.54%) | Hourly BBV | 0 () | Intraday Trend | 1.3% | | | |
|
1 - 5 Day Possible Target | $36.31(-21.07%) | Resistance Level | $47.7 | 5 Day Moving Average | $44.5(3.37%) | 10 Day Moving Average | $46.67(-1.44%) | 20 Day Moving Average | $47.7(-3.56%) | To recent high | -31.1% | To recent low | 8.2% | Market Cap | $N/A | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |